Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Get Rating) – Cantor Fitzgerald reduced their FY2023 earnings per share estimates for Zevra Therapeutics in a note issued to investors on Tuesday, May 16th. Cantor Fitzgerald analyst L. Chen now anticipates that the company will post earnings per share of ($1.45) for the year, down from their prior estimate […]
Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Get Rating) traded down 10% during trading on Tuesday . The stock traded as low as $4.41 and last traded at $4.43. 351,489 shares changed hands during mid-day trading, an increase of 51% from the average session volume of 233,420 shares. The stock had previously closed at $4.92. Analyst Upgrades […]
StockNews.com started coverage on shares of Zevra Therapeutics (NASDAQ:KMPH – Get Rating) in a research report sent to investors on Sunday morning. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Zevra Therapeutics Stock Performance Zevra Therapeutics has a 52-week low of $4.00 and a 52-week high of $6.92. The firm has […]
StockNews.com began coverage on shares of Zevra Therapeutics (NASDAQ:KMPH – Get Rating) in a research report released on Sunday. The brokerage issued a hold rating on the specialty pharmaceutical company’s stock. Zevra Therapeutics Price Performance Zevra Therapeutics has a one year low of $4.00 and a one year high of $6.92. The company has a […]